Your browser doesn't support javascript.
loading
The efficacy of culture-guided versus empirical therapy with high-dose proton pump inhibitor as third-line treatment of Helicobacter pylori infection: A real-world clinical experience.
Wang, Jiunn-Wei; Hsu, Ping-I; Lin, Ming-Hong; Kao, John; Tsay, Feng-Woei; Wu, I-Ting; Shie, Chang-Bih; Wu, Deng-Chyang.
Afiliação
  • Wang JW; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Hsu PI; Department of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan.
  • Lin MH; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • Kao J; Division of Gastroenterology, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan.
  • Tsay FW; Department of Microbiology and Immunology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Wu IT; Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Shie CB; Division of Gastroenterology, Department of Internal Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
  • Wu DC; Division of Gastroenterology, Department of Internal Medicine, An Nan Hospital, China Medical University, Tainan, Taiwan.
J Gastroenterol Hepatol ; 37(10): 1928-1934, 2022 Oct.
Article em En | MEDLINE | ID: mdl-35816187

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Helicobacter pylori / Infecções por Helicobacter / Anti-Infecciosos Limite: Humans Idioma: En Revista: J Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Helicobacter pylori / Infecções por Helicobacter / Anti-Infecciosos Limite: Humans Idioma: En Revista: J Gastroenterol Hepatol Ano de publicação: 2022 Tipo de documento: Article